Pharma's Almanac TVPA TV
  • Follow the Completed Journey
  • Companies We've Met
  • AES Clean Technology
  • Altis Biosystems
  • Arranta Bio
  • Avara Pharmaceutical Services
  • Avid Bioservices
  • BioVectra
  • Centaur BPS
  • Dynamk Capital
  • ECRI
  • Evolve Biologics
  • Federal Equipment Company
  • Globyz
  • Inceptor Bio
  • IPS-Integrated Project Services
  • Olon
  • Pii
  • Polpharma Biologics
  • PPD
  • RoosterBio
  • SanaClis
  • Sanofi AIS
  • SGD Pharma
  • SPI Pharma
  • TriRx Pharmaceutical Services
  • Yourway
  • Follow the Completed Journey
  • Companies On The Road
  • Follow The Artist
  • ABS
  • aCGT Vector
  • Alconox Inc.
  • Andelyn Biosciences
  • Arranta Bio
  • Avid Bioservices
  • BDD
  • BIOVECTRA
  • DPS Group
  • Dynamk Capital
  • Environmental Systems Corporation
  • Federal Equipment Company
  • Genesis AEC
  • Globyz Biopharma Services
  • Grifols Partnership
  • IDT Biologika
  • Inceptor Bio
  • IPS-Integrated Project Services
  • Kineticos Life Sciences
  • MilliporeSigma
  • Montana BioScience Alliance
  • Olon
  • Rentschler Biopharma
  • SanaClis
  • Scorpion Biological Services
  • Secant Group
  • Tapemark
  • VITRONIC
Dashboard
Your Name
Your Email
  • Manage Account
  • Sign Out
Sign In
Register
    • Topics
        Products
        • ADC
        • API - Small Molecule
        • Biologics
        • Biopharmaceuticals
        • Biosimilars
        • Cell and Gene Therapy
        • DNA
        • Drug Product
        • Drug Substance
        • Equipment
        • Generics
        • Immunotherapy
        • Injectables
        • Monoclonal Antibody
        • Novel Therapeutics
        • Oral Solid Dosage
        • Orphan Drugs
        • Parenterals
        • Stem Cells
        • Vaccine
        Services
        • Big Data
        • Bioprocessing
        • Clinical Trials
        • Continuous Manufacturing
        • Diagnostics
        • Drug Delivery
        • Drug Development
        • Drug Discovery
        • Facility
        • Formulation
        • Innovation
        • Oncology
        • Patient Adherence
        • Patient Centric
        • Preclinical
        • Process Development
        • Quality
        • Regulatory
        • Research
        • Serialization
        Segment
        • Biomanufacturing
        • Biotechnology
        • CDMO
        • Consulting
        • CRO
        • Engineering
        • Equipment
        • Excipients
        • Healthcare
        • Intermediates
        • Logistics
        • Manufacturing
        • Packaging
        • Supply Chain
        Business
        • Agreement
        • Appointment
        • Business
        • Capacity Expansion
        • Collaboration
        • Growth
        • Investment
        • Licensing
        • M&A
        • Market Expansion
        • Market Intelligence
        • Market Prediction
        • New Facility
        • Strategic Partnership
    • Magazine
      • Archive
    • Reports
      • 2021 Cell & Gene Therapy Report
      • 2021 Monoclonal Antibody & Recombinant Protein Market Report
      • 2022 Sterile Drug Market Report
      • 2022 API Market Report
      • 2022 OSD Market Report
    • Community
    • Company A to Z
    • Follow the Journey
    • Companies On The Road
    • Follow The Artist
    • More+
      • Staffing
      • Media Kit

    FUJIFILM

    11 Articles Available

    Can't find what you're looking for? Try our advanced search.

    Facility Acquisition

    Fujifilm Completes Acquisition of a Dedicated Cell Therapy Manufacturing Facility from Atara Biotherapeutics, Inc.
    PR-M04-22-01

    Facility Acquisition

    Fujifilm Expands its Advanced Therapies CDMO Business with the Acquisition of a Dedicated Cell Therapy Manufacturing Facility from Atara Biotherapeutics, Inc.
    PR-M01-22-18

    Strategic Alliance

    FUJIFILM Cellular Dynamics and PhenoVista Biosciences Announce Strategic Alliance to Improve the Drug Discovery Process
    PR-M01-22-05

    Partnership

    Fujifilm Partners with Dr. Reddy's and Global Response Aid for Deployment of a COVID-19 Treatment Drug Outside of Japan
    PR-M06-20-NI-043

    Liposome Formulations

    FUJIFILM Toyama Chemical Announces Completion of Japan’s First Manufacturing Facility for Commercial Liposome Formulations
    PR-M12-19-NI-015

    Partnership

    Fujifilm Expands RIS Revenue Cycle Solutions With Availity Partnership
    PR-M06-18-NI-033

    Viral Vector

    Flexible, Mobile, Modular: High-Containment Viral Vector Center of Excellence
    PAP-Q2-18-CL-005

    Expansion

    Fujifilm Announces The Expansion Of Its Fill Finish Services
    PR-M05-18-NI-095

    Acquistion

    FUJIFILM Expands into Bio-Medical Business with Acquisition
    PR-M03-18-NI-103

    Imaging

    Fujifilm Debuts ASPIRE Bellus II, A New Multimodality Mammography Workstation
    PR-M03-18-NI-041

    Investment

    FUJIFILM Plans $1 Billion Capacity Expansion in U.S., U.K.
    PAO-M11-17-NI-029

    About Us
    That’s Nice Staffing
    More
    Media Kit Download Current Issue
    Your Account
    Manage Your Account Dashboard Sign Out
    Sign In Register
    Help
    Contact Us Support
    Nice Insight/That’s Nice

    89 Fifth Avenue
    Fifth Floor
    New York
    NY 10003-3020

    New York – San Diego – Chicago
    London – Frankfurt – Shanghai

    Nice Insight is the market research division of That’s Nice LLC, the leading marketing agency serving life sciences.

    © PHARMA’S ALMANAC 2022 Terms and Conditions